Health Insight May 2002: European drugs industry must keep pace with US
ministers and top-level representatives of the UK pharmaceutical industry
met in London last month to discuss how to respond to a recent EU report
on improving the competitiveness of the European pharmaceutical industry.
Co-chaired by UK Health Minister Lord Philip Hunt and Tom McKillop, CEO of
AstraZeneca, this was the second meeting of the Ministerial Industry
Strategy Group (MISG).
The EU report, produced by a Group of Ten (known as G10), bringing together government, industry and other parties from around Europe, was a response to the perception that over the last decade the European pharmaceutical industry has fallen behind the US. The report, presented to Commission President Romano Prodi earlier in the month, set out fourteen recommendations for action. The UK, as a leading location for the pharmaceutical industry in Europe, will be working with its partners in Europe to ensure that the recommendations are followed through. Lord Hunt said, ‘The UK has a thriving and successful pharmaceutical industry, and we want to keep it that way.’
Source: Press release (DoH)
Return to the main Health insight page | the main May 2002 Health insight page
|Produced in United Kingdom by The British Council © 2002. The British Council is the United Kingdom's international organisation for educational and cultural relations. Registered in England as a Charity.|